- Home
- IMMX vs GORO Comparison
IMMX vs GORO Comparison
Compare IMMX & GORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- GORO
- Stock Information
- Founded
- IMMX 2014
- GORO 1998
- Country
- IMMX United States
- GORO United States
- Employees
- IMMX N/A
- GORO N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- GORO Precious Metals
- Sector
- IMMX Health Care
- GORO Basic Materials
- Exchange
- IMMX Nasdaq
- GORO Nasdaq
- Market Cap
- IMMX 50.1M
- GORO 53.3M
- IPO Year
- IMMX 2021
- GORO N/A
- Fundamental
- Price
- IMMX $1.75
- GORO $0.51
- Analyst Decision
- IMMX Strong Buy
- GORO Strong Buy
- Analyst Count
- IMMX 1
- GORO 1
- Target Price
- IMMX $7.00
- GORO $1.25
- AVG Volume (30 Days)
- IMMX 47.5K
- GORO 2.7M
- Earning Date
- IMMX 05-08-2025
- GORO 05-01-2025
- Dividend Yield
- IMMX N/A
- GORO N/A
- EPS Growth
- IMMX N/A
- GORO N/A
- EPS
- IMMX N/A
- GORO N/A
- Revenue
- IMMX N/A
- GORO $73,897,000.00
- Revenue This Year
- IMMX N/A
- GORO N/A
- Revenue Next Year
- IMMX N/A
- GORO $48.90
- P/E Ratio
- IMMX N/A
- GORO N/A
- Revenue Growth
- IMMX N/A
- GORO N/A
- 52 Week Low
- IMMX $1.26
- GORO $0.12
- 52 Week High
- IMMX $3.13
- GORO $0.74
- Technical
- Relative Strength Index (RSI)
- IMMX 41.38
- GORO 53.13
- Support Level
- IMMX $1.64
- GORO $0.45
- Resistance Level
- IMMX $1.90
- GORO $0.66
- Average True Range (ATR)
- IMMX 0.14
- GORO 0.07
- MACD
- IMMX 0.00
- GORO -0.00
- Stochastic Oscillator
- IMMX 10.44
- GORO 33.52
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About GORO Gold Resource Corporation
Gold Resource Corp is a gold and silver producer, developer, and explorer with operations in Oaxaca, Mexico, and Nevada, USA. It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America.